Among the ceRNAs of miR-944, highly expressed circSERPINA3, circHAS2, SNHG6, and PRNCR1 can be used as biomarkers for poor clinicopathological features and poor prognosis in cancer patients. This evidence concerns the gene SNHG6 and cancer.